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Abstract
Background: Current 2005 guidelines for advanced cardiac life support strongly recommend immediate
defibrillation for out-of-hospital cardiac arrest. However, findings from experimental and clinical studies have
indicated a potential advantage of pretreatment with chest compression-only cardiopulmonary resuscitation (CPR)
prior to defibrillation in improving outcomes. The aim of this meta-analysis is to evaluate the beneficial effect of
chest compression-first versus defibrillation-first on survival in patients with out-of-hospital cardiac arrest.
Methods: Main outcome measures were survival to hospital discharge (primary endpoint), return of spontaneous
circulation (ROSC), neurologic outcome and long-term survival.
Randomized, controlled clinical trials that were published between January 1, 1950, and June 19, 2010, were identi-
fied by a computerized search using SCOPUS, MEDLINE, BIOS, EMBASE, the Cochrane Central Register of Controlled
Trials, International Pharmaceutical Abstracts database, and Web of Science and supplemented by conference pro-
ceedings. Random effects models were used to calculate pooled odds ratios (ORs). A subgroup analysis was con-
ducted to explore the effects of response interval greater than 5 min on outcomes.
Results: A total of four trials enrolling 1503 subjects were integrated into this analysis. No difference was found
between chest compression-first versus defibrillation-first in the rate of return of spontaneous circulation (OR 1.01
[0.82-1.26]; P = 0.979), survival to hospital discharge (OR 1.10 [0.70-1.70]; P = 0.686) or favorable neurologic
outcomes (OR 1.02 [0.31-3.38]; P = 0.979). For 1-year survival, however, the OR point estimates favored chest
compression first (OR 1.38 [0.95-2.02]; P = 0.092) but the 95% CI crossed 1.0, suggesting insufficient estimate
precision. Similarly, for cases with prolonged response times (> 5 min) point estimates pointed toward superiority
of chest compression first (OR 1.45 [0.66-3.20]; P = 0.353), but the 95% CI again crossed 1.0.
Conclusions: Current evidence does not support the notion that chest compression first prior to defibrillation
improves the outcome of patients in out-of-hospital cardiac arrest. It appears that both treatments are equivalent.
However, subgroup analyses indicate that chest compression first may be beneficial for cardiac arrests with a
prolonged response time.
Background
There are an estimated 294,851 emergency medical ser-
vices (EMS)-assessed out-of-hospital cardiac arrests
(OHCA) in the United States each year [1,2]. The most
common underlying arrhythmias of witnessed arrests
are ventricular tachycardia and ventricular fibrillation
[3]. Despite major attempts to improve the chain of
survival, survival rates for OHCA remain the same at
7.6% for over 30 years [4]. Average rates of survival to
hospital discharge are as low as 0.3% in some commu-
nities [5,6] and depend strongly not only on the time to
initiation of chest compressions but also on the time
until defibrillation and the underlying rhythm [3]. While
the first two factors can be influenced, they cannot be
performed simultaneously. Controversy about priority
has resulted from experimental and clinical data.
Current guidelines of the European Resuscitation
Council (ERC) and the American Heart Association
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any medium, provided the original work is properly cited.(AHA) were last updated in 2005 and emphasize the
importance of early defibrillation. The International Liai-
son Committee on Resuscitation (ILCOR), ERC and
AHA clearly prioritize early defibrillation [7,8]. However,
the AHA guidelines state that in cases of nonwitnessed
events, one cycle of cardiopulmonary resuscitation
(CPR)/chest compressions may be considered before
defibrillation (class IIb recommendation) [7]. The inter-
val from compression to defibrillation is highly critical
as impaired myocardial oxygenation distinctively
decreases defibrillation success rates while myocardial
preoxygenation may improve outcome [9,10].
There is, however, clinical equipoise whether profes-
sional chest compression only promptly followed by
defibrillation could increase myocardial “readiness” for
defibrillation. Data from the first randomized clinical
trials (RCT) have shown conflicting results, but most
studies were limited in size and underpowered to allow
definite conclusions. A recent large-scale observational
study indicated potential benefit for preshock chest
compressions [11].
This is the first meta-analysis to systematically review
the current research on chest compression first as com-
pared to defibrillation first on outcomes in patients with
OHCA.
Methods
The study was performed according to PRISMA guide-
lines (Additional file 1) [12]. Planning and study design
were done by two authors (CS, PM), including creation
of an electronic database with variables of interest
(Microsoft Excel). Primary and secondary endpoints,
variables of interest and search strategy (databases,
sources for unpublished data) were defined in a strategy
outline which can be obtained from study authors on
request.
Data Sources and Searches
A search was conducted of SCOPUS, MEDLINE (via
PubMed), BIOS, EMBASE, the Cochrane Central Register
of Controlled Trials, International Pharmaceutical
Abstracts database, and Web of Science from January 1,
1950, to June 19, 2010, supplemented by the conference
proceedings of the American Heart Association (2006-
2009), the American College of Cardiology (2006-2010),
the European Society of Cardiology (2001-2009), the
symposium on Transcatheter Cardiovascular Therapeu-
tics (2006-2009), the World Congress of Cardiology
(2006-2009) and the European Resuscitation Council
Scientific Symposium (2006-2009). We also considered
published review articles, editorials, and Internet-based
sources of information (http://www.tctmd.com, http://
www.theheart.org, http://www.europcronline.com, http://
www.cardiosource.com, http://www.crtonline.com and
Google scholar). For details on search strategy for MED-
LINE, see Additional file 2. Similar but adapted search
terms were used for the other literature databases.
Study selection
In a two-step selection process, two investigators (PM,
BH) independently reviewed the titles and abstracts of
all citations to identify potentially relevant studies and
to exclude duplicates. The corresponding publications
were reviewed in full text by three investigators (CS,
PM, BH) to assess whether studies met the following
inclusion criteria: 1) randomized treatment assignment
to chest compression first versus defibrillation first, 2)
human study and 3) included outcome data on one of
the four following clinical outcomes: return of sponta-
neous circulation, survival to hospital discharge, neuro-
logical outcome at discharge or survival at 1 year
(Figure 1). Reviewers were not blinded to study authors
or outcomes. Final inclusion of studies was based on the
agreement of three investigators (CS, PM, BH).
Data extraction and quality assessment
Relevant information from the articles, including base-
line clinical characteristics of the study population and
outcome measures, were extracted by two reviewers
(PM, BH) using the prepared standardized extraction
database (MS Excel); data on outcome (see endpoint
definition below), total patient numbers per group, and
covariables of interest (average age, gender, witnessed
arrest, bystander CPR, response time upon arrival of
emergency medical service EMS as defined by each
study) were extracted. The quality of each trial was
assessed using the Jadad scale to ensure sufficient qual-
ity but was not implemented in the analysis due to rele-
vant limitations of such approaches [13,14]. Absolute
numbers were recalculated when percentages were
reported. All corresponding authors of included trials
were contacted to ensure accuracy of the data extraction
and in an attempt to obtain more information and indi-
vidual patient level data.
Endpoints
The primary endpoint of this analysis was survival to
hospital discharge. However, the endpoints are pre-
sented in a chronologic order as follows:
1. Return of spontaneous circulation (ROSC)
2. Survival to hospital discharge
3. Favorable neurologic outcome at discharge (cere-
bral performance category (CPC) score 1 or 2)
4. Long-term outcome (survival at 1 year)
“Favorable neurological outcome” was defined as a
CPC score of 1 or 2 (no or moderate cerebral disability).
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endpoint
We regarded a relative change of at least 20-25% as clini-
cally relevant. Power analyses of prospective randomized
trials evaluating interventions for OHCA (predefibrilla-
tion chest compression, therapeutic hypothermia) used
variable definitions for “clinically relevant” differences in
survival, ranging from 32-550% [15-19]. Therapeutic
hypothermia as one of few measures with proven benefits
in OHCA showed a 35% increase in survival in a recent
meta-analysis of randomized trials [20]. Since survival is
such an essential endpoint, we regard a relative change of
at least 20-25% as already clinically relevant, while on the
other hand, a lower threshold would not be very mean-
ingful in the context of the general low survival to dis-
charge rate for OHCA (average 7.6%) [4]. This would
increase the risk to detect incidental differences.
Data synthesis and analysis
All analyses were performed on an intent-to-treat basis.
Data of included studies were combined to estimate the
pooled treatment effect (odds ratio, OR) for the chest
compression-first compared to the defibrillation-first
groups. Calculations were based on a DerSirmonian and
Laird random effects model [21]. Sensitivity analyses
were conducted using alternative meta-analytical
approaches such as the Hartung-Knapp method, which
tends to be more conservative, and by meta-regression
analyses (mixed-effects model) for the subgroups as
defined below (R package “metafor”) [22,23]. Continuity
correction was used when no event occurred in one
group to allow calculation of an odds ratio [24]. We
used the rank correlation test to assess the risk for pub-
lication bias [25,26]. Heterogeneity among trials was
quantified with Higgins’s and Thompson’s I
2. I
2 can be
interpreted as the percentage of variability due to het-
erogeneity between studies rather than sampling error.
On the basis of findings in a previous observational
study, an ap r i o r isubgroup analysis of response time
from event to EMS arrival (≤5m i nv e r s u s> 5m i n )w a s
also conducted [27]. Further, a meta-regression analysis
was performed on the basis of the mean response inter-
vals of each study using a mixed-effects model.
Weighted average incidence of events for the chest com-
pression-first and the defibrillation-first groups were cal-
culated on the basis of a random effect analysis using a
Freeman-Tukey double arcsine transformation and the
inverse variance method [28]. Findings are presented as
point estimates and 95% confidence intervals. Analyses
have been performed by two investigators independently
(GK, PM). All analyses were performed with R version
2.10.1 (packages “meta,”“ rmeta,” and “metafor”) [29].
Figure 1 Flow chart depicting the outline of the search and selection strategy. RCT, randomized controlled trial.
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Description of included studies
A total of 245 abstracts were reviewed, and 79 of those
were subsequently reviewed as full text articles; finally,
four randomized trials enrolling 1503 subjects satisfied
the predetermined inclusion criteria (Figure 1) [15-18].
Tables 1, 2, 3 summarize the characteristics and quality
scores of the four trials.
Outcomes
Return of spontaneous circulation (ROSC)
The pooled analysis did not reveal a relevant difference
in the overall chance for ROSC between the chest com-
pression-first and the defibrillation-first approach (OR
1.01 [0.82-1.26]; P = 0.979; heterogeneity: I
2 =0 % ,P =
0.79) (Figure 2a). The weighted average proportion of
patients in whom ROSC was achieved was 39.2% [19.8-
60.5%] for the chest compression-first group and 37.3%
[17.0-60.2%] for the defibrillation-first group.
Survival to hospital discharge
As summarized for all response times in Figure 2b, the
direct comparison between the chest compression-first
and the defibrillation-first approach did not reveal a
relevant difference (OR 1.10 [0.70-1.70]; P = 0.686; het-
erogeneity: I
2 = 34.4%, P = 0.206). The average weighted
proportion of patients able to leave the hospital after
cardiac arrest was 12.0% [6.4-19.1%] for the chest com-
pression-first group as compared to 11.4% [7.1-16.6%]
for the defibrillation-first group.
Favorable neurologic outcome
The average weighted proportion of patients with favor-
able neurological status was 13.7% [4.9-25.9%] after
chest compression first and 13.3% [9.0-18.3%] after defi-
brillation first. As seen in Figure 2c, patients who were
treated with chest compression first did not show an
increased likelihood of a “favorable neurologic outcome”
(as defined by a CPC score of 1 or 2) compared to
those with defibrillation first (OR 1.02 [0.31-3.38];
P = 0.979; heterogeneity: I
2 = 74.9%, P = 0.05).
One-year survival
As shown in Figure 2d, the OR point estimates favored
a chest compression-first approach (OR 1.38 [0.95-2.02];
P = 0.092; heterogeneity: I
2 =0 % ,P = 0.647). However,
the 95% confidence intervals crossed 1.0, indicating
insufficient precision of the effect size estimation and
resulting in statistical nonsignificance. The average
weighted proportion of patients able to leave the hospi-
tal after cardiac arrest with chest compression first it
was 11.0% [4.8-19.5%] as compared to 8.6% [4.8-13.4%]
for patients treated with defibrillation first.
Figure 3 summarizes the chance of survival of patients
involved in the included trials after cardiac arrest up to
1 year after the event. As mentioned above, ROSC was
achieved in approximately 40% of patients with OHCA
included in these trials, chance for survival to hospital
discharge was around 12.0% and similar between both
treatment groups, while the survival chance at 1 year
was 11.0% with chest compression first and 8.6% with
defibrillation first.
Subgroup Analyses Based on Response Intervals (Call to
EMS Arrival)
In Figure 4, the studies are ordered according to their
average EMS response times. OR point estimates of stu-
dies with shorter EMS response times favored a defibril-
lation-first approach. The longer the EMS response
times, the OR point estimates favored chest compres-
sion first followed by defibrillation. However, for all
these OR estimates, the 95% confidence intervals
crossed 1.0; thus, none of the differences were statisti-
cally significant.
Table 1 Characteristics of included studies
Author Year Location Group Patients
(n)
Age
(yrs)
Male
(%)
Witnessed
(%)
Bystander CPR performed
(%)
Response time
(min)
Jost [15] 2010 France Defi.-first 424 62 79 86 21 10:54
Compr.-
first
421 65 78 87 21 10:30
Baker [16] 2008 Australia Defi -first 105 66* 80 79 58 08:14
Compr.-
first
97 65* 84 84 59 07:41
Jacobs [17] 2005 Australia Defi -first 137 62 80 74 54 09:00
Compr.-
first
119 64 80 80 64 09:20
Wik [18] 2003 Norway Defi -first 96 80* 89 94 56 11:42
Compr.-
first
104 71* 85 91 62 12:00
*Median; Compr-first: chest compressions before defibrillation; Defi.-first: immediate defibrillation before chest compressions; response time: time-to arrival of
ambulance.
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ROSC A ss h o w ni nF i g u r e5 a ,f o rr e s p o n s et i m e≤5
minutes, the OR to achieve ROSC was not significantly
different between chest compression first and defibrilla-
tion first (OR 1.05 [0.58-1.88]; P = 0.872; heterogeneity:
I
2 = 0%, P = 0.73).
Survival to discharge The point estimates of the OR for
this outcome were in disfavor of predefibrillation chest
compressions (OR 0.69 [0.36-1.32]; P = 0.263; heteroge-
neity: I
2 =0 % ,P = 0.954) (Figure 5b). The 95% confi-
dence interval crossed 1.0, indicating inadequate
precision of the effect estimate, resulting in statistical
nonsignificance.
Neurologic outcome As Figure 5c shows, the OR point
estimate was in disfavor of predefibrillation chest com-
pression approach (OR 0.57 [0.23-1.43]; P =0 . 3 0 0( h e t -
erogeneity: 0%; P = 0.370). Again, the 95% confidence
interval crossed 1.0, and the difference was therefore
not statistically significant.
5 minutes",1,0,2,0,0pc,0pc,0pc,0pc>Response Interval >5
minutes
ROSC No relevant differences were found for patients
with a response time >5 minutes in ROSC (Figure 6a),
the OR was 1.10 [0.67-1.78]; P = 0.705 (heterogeneity:
62.4%; P = 0.0712).
Survival to discharge The point estimate for the OR
pointed toward superiority of chest compression first,
but the confidence interval crossed 1.0; thus, the finding
was not statistically significant (OR 1.45 [0.66-3.20];
P = 0.353; heterogeneity: 59.1%; P = 0.062) (Figure 6b).
Neurologic outcome As Figure 6c illustrates, there was
no relevant difference between the two groups (OR 1.02
[0.31-3.38]; P = 0.879; heterogeneity: I
2 = 84.2%;
P = 0.012).
Meta-regression analysis based on mean response
intervals
This analysis showed a significant effect of the mean
response interval of each study in the control arm on
the effect of predefibrillation chest compression; the
point estimates of the OR pointed toward inferiority of
predefibrillation chest compression for studies with
short mean response intervals but toward superiority for
studies with longer mean response intervals (Additional
file 3; Supplementary Figure 1). This response interval
effect was statistically significant. The slope of the meta-
regression was 0.0051 [0.0004-0.0097]; P = 0.033. That
is, for every absolute increase of 1 time unit (1 second)
in the response time, the log odds ratio increased by
0.0051 (in direction to superiority of a chest compres-
sion-first approach). At around 600 seconds (10 min)
response time, the regression line crosses OR 1.0 (equi-
poise between the two interventions). Additional file 4,
Supplementary Table 6 gives an overview of variable
response intervals with corresponding predicted odds
ratios.
Sensitivity analyses
The analysis performed with the Hartung-Knapp meta-
analytical approach and by a mixed-effects meta-
regression analysis revealed almost identical results
(see Additional file 5, Supplementary Tables 3-5. Also,
a sensitivity analysis was conducted without the study
by Jost et al. [15], as this study did not exclusively test
Table 2 Characteristics of included studies
Author Year Group CPR pretreatment (sec) Compression to ventilation ratio No. of consecutive shocks
Jost 2010 Defi -first Cardio-pump* 3
Compr.-first 60 Cardio-pump* 1
Baker 2008 Defi -first 3
Compr.-first 180 15:2 3
Jacobs 2005 Defi -first 3
Compr.-first 90 5:1 3
Wik 2003 Defi -first 3
Compr.-first 180 5:1 3
* Trademark (manufacturer: Ambu, Denmark). Compr-first: chest compressions before defibrillation;
Defi.-first: immediate defibrillation before chest compressions; sec: seconds
Table 3 Quality of included studies (Jadad score)
Author Randomized Appropriate
randomization
Double
blind
Appropriate blinding
(single blind)
Drop outs appropriately
declared
Score
Jost Yes Yes No Yes Yes 4/5
Baker Yes Yes No Yes Yes 4/5
Jacobs Yes Yes No Yes Yes 4/5
Wik Yes Yes No Yes Yes 4/5
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Page 5 of 13Figure 2 Forest plot of odds ratios (OR) of (a) ROSC, (b) survival to hospital discharge (primary endpoint), (c) favorable neurologic
outcome, and (d) 1-year survival. Horizontal bars indicate 95% confidence intervals. Size of markers represents study weight in meta-analysis.
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of three consecutive shock applications versus a single
shock at a time. Also, most patients did not receive
bystander CPR; CPR was initiated in most cases by
firefighters using a CPR device instead of manual com-
pressions. When excluding this study, the results did
n o tc h a n g ed e s p i t et h ec o n s i d e r a b l ew e i g h t( s t u d ys i z e )
of this study in this analysis (data not presented).
Publication bias assessment
Regarding the primary endpoint, the rank correlation
test was not suggestive for publication bias, P = 0.588.
Discussion
This is the first meta-analysis evaluating the effect of
chest compression first versus defibrillation first in
patients having out-of-hospital cardiac arrest. We
included four randomized, controlled clinical trials with
1503 subjects. Overall, our findings suggest that there
was no significant difference between the two groups in
general. However, our subgroup analyses of patients
with a response interval >5 min found point estimates
that pointed toward superiority of a chest compression-
first approach and vice versa for the subgroup with
response interval ≤5 min. The point estimate for the 1-
year survival results pointed toward a lower 1-year mor-
tality for chest compression-first patients, which was
mainly driven by studies with longer EMS response
times [15,18]. However, the 95% confidence intervals of
these subgroup and long-term analyses crossed 1.0, indi-
cating insufficient precision of the effect estimates and
resulting in statistical nonsignificance. These analyses
were based on smaller patient numbers.
Rational for Chest Compressions Prior to Defibrillation
Chest compressions serve to empty the right ventricle
(RV) and to avoid RV distension during VF, which helps
to reduce the risk of occurrence of “nonperfusing” post-
defibrillation rhythms (e.g., pulseless electrical activity or
asystole) [30,31]. Two experimental animal studies on
ventricular defibrillation have demonstrated that chest
compression first may improve defibrillation success in
comparison to the standard defibrillation first approach.
A randomized study in swine conducted by Berg et al.
and a study by Niemann et al. in dogs both showed
higher efficiency for chest compression prior to defibril-
lation [32,33]. Data from a study conducted on humans
showed that even short preshock pauses were found to
strongly correlate with lower defibrillation success [34].
Accordingly, a large observational study by Cobb et al.
demonstrated improved survival for patients treated for
out-of-hospital cardiac arrest after implementation of
chest compression-first protocol compared to the pre-
ceding 42 months with the standard defibrillation-first
approach [27]. Similarly, a study including 886 patients
of Bobrow et al. performed in Arizona implementing a
protocol of 200 uninterrupted chest compressions before
defibrillation (single shock) showed a remarkable
increase in survival-to-hospital discharge, from 1.8% to
5.4% after protocol implementation [35,36]. Yet, despite
all of the above data from experimental and observa-
tional studies, our meta-analysis based on randomized
clinical trials in humans shows that both treatments
appear to be equivocal, with point estimates that favor
chest compression first regarding long-term outcomes.
Several aspects could explain this controversy. First,
findings from experimental animal studies may not
apply to humans, especially since most models use elec-
trical induction of ventricular fibrillation, which may not
appropriately reflect the majority of cardiac arrests in
humans [37]. In a more recent study in swine using an
acute myocardial ischemia model, 24-hr survival with a
favorable neurological outcome was less likely when
chest compressions were performed prior to defibrilla-
tion [38]. Second, observational studies [27,35] are more
prone to confounding than randomized trials. Because
we decided ap r i o r ito include only randomized, con-
trolled trials in our meta-analysis, our results may differ
from these large observational studies. Finally, it may be
that the treatment effect of chest compression first may
be dependent on the response interval from the time of
call to EMS response. Further research, with patient-
Figure 3 Survival of enrolled patients after cardiac arrest
(average percentage and 95% confidence intervals).
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this finding is consistent.
Short- versus longer-duration cardiac arrest
The possible difference in treatment effect for longer-
lasting (response interval >5 min) makes plausible sense
from a pathophysiological standpoint. Cardiac arrest
(due to ventricular tachycardia/fibrillation (VT/VF)) is
definitively not a static event. Rather, it is a dynamic
process with sometimes continuous transitions starting
with VT, transforming into coarse and then into fine
amplitude VF and finally into asystole; these different
electrocardiogram morphologies are obviously associated
with different degrees of defibrillation success [39]. Dur-
ing the course of VF high-energy phosphates are pro-
gressively depleted, which also decreases the chances for
successful defibrillation [40].
Niemann et al. demonstrated the superiority chest
compression first in a dog model [33], but found better
outcomes for defibrillation first in a subsequent study
[41]. In this second study, VF duration was relevantly
shorter (5 min versus 7.5 min in the first study). Another
study conducted in dogs specifically evaluated different
VF durations, showing differential results based on the
duration of VF. For short-lasting VF arrests (< 3 min),
defibrillation first was superior to chest compression first
[42]. It has to be considered, however, that most experi-
mental animal studies used electrical induction of VF,
which may not be identical to ischemia-induced VF [37].
The study by Cobb et al. included in our analysis showed
the most prominent benefit for chest compression first if
response time was >4 min [27].
In 2002, Weisfeldt et al. proposed a three-phase time-
sensitive model for treatment of sudden cardiac arrest:
the electrical phase (early phase during the first around
0-4 min where immediate defibrillation may be optimal,
the circulatory phase (4-10 min) where predefibrillation
chest compressions could be meaningful, and the meta-
bolic phase (> 10 min), where survival rates are poor in
general [39]. The authors stated in their editorial that
“phase-specific research is needed to extend knowledge
of the importance of time on resuscitation, such as test-
ing early defibrillation and public access defibrillation
programs during the electrical phase and testing chest
compression and vasoconstrictors first during the circu-
latory phase.” [39]. Our findings support the view of
Weisfeld et al. as illustrated in Figure 4 and as shown in
the subgroup analyses of patients with longer versus
those with shorter response intervals.
Limitations of this study
It has to be considered that nonstratified overall results
showed odds ratios very close to 1.0; that is, no treat-
ment effect with fairly narrow confidence (precision)
intervals and with very little heterogeneity. In contrast,
OR point estimates pointed toward superiority of prede-
fibrillation chest compressions for those cardiac arrests
with prolonged EMS response, while in patients with
shorter EMS intervals these OR estimates pointed
toward superiority of a defibrillation-first approach (Fig-
ures 5 and 6). Owing to the smaller sample sizes in
Figure 4 Odds ratio (OR) for primary endpoint “survival to hospital discharge” and response time. Horizontal bars indicate 95%
confidence intervals. Size of markers represents study weight in meta-analysis.
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reduced precision of these estimates. The confidence
intervals for these subgroup analyses crossed 1.0; i.e.,
the result was statistically not significant. It is possible
that there is in fact a difference that was not detected
by our analysis due to limited statistical power. An
interaction between optimal treatment and response
time is further supported by the observation that the
odds ratios were influenced by the average response
intervals of the individual studies (Figure 3 and Addi-
tional file 1). However, the meta-regression analysis
(Additional file 1), even though in line with the findings
of the subgroup analyses, has to be interpreted with
care because it is based on summary measure (mean
response intervals of each study) and not on individual
response intervals. Meta-analyses are useful for synthe-
sizing the literature and to explore areas for further
exploration rather than to provide a definitive
Figure 5 Forest plot of odds ratios (OR) of the subgroup of patients with response time ≤5 min for (a) ROSC, (b) survival to hospital
discharge, and (c) favorable neurologic outcome. Horizontal bars indicate 95% confidence intervals. Size of markers represents study weight
in meta-analysis.
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could be conducted with patient-level data to assess
whether the overall pooled results are consistent with
the individual-level data.
RCT data are considered the “golden standard” and
superior to observational studies. Clearly, the latter are
more prone to be biased by confounding, and, accord-
ingly, we considered RCT exclusively in this meta-analy-
sis. Nevertheless, there are caveats for RCT also [43];
this is especially true in the context of human emer-
gency medicine research. The vast majority of patients
assessed for inclusion in these trials were finally not
eligible because of predefined exclusion criteria or
owing to logistical reasons. Thus, the patient selection
associated with RCT potentially complicates generaliz-
ability of findings into routine clinical practice. For
example, bystander CPR rate ranged from 54-64% in
three of the included trials, while the AHA estimates
the average bystander CPR rate in the United States to
be 31.4% [1]. Future research will need to be conducted
on communities that may be more generalizable than
the study populations in this analysis.
A further limitation of this study is the heterogeneity
of the study protocols. Three of the four included trials
Figure 6 Forest plot of odds ratios (OR) of group with response time >5 min for (a) ROSC, (b) survival to hospital discharge and (c)
good neurologic outcome. Horizontal bars indicate 95% confidence intervals. Size of markers represents study weight in meta-analysis.
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[16-18],
while one study utilized a single shock application (as
advocated in the current 2005 guidelines) in the chest
compression first group [15]. All four studies did not
control for the quality of chest compressions. The qual-
ity of chest compressions has a key impact on outcome
and is often insufficient, even for in-hospital cardiac
arrests [34] and even in some experimental studies [44].
We cannot exclude that the quality of compressions in
the included studies was insufficient, and as a conse-
quence, the studies were unable to show a benefit.
Because of the differences in study protocols, we chose
to use a random effects model rather than a fixed-effect
model for data analysis.
Finally, we did not have the complete set of individual
patient data, and our analyses are thus based on study-
level data. Therefore, we could not adjust the analysis
for covariables. For example, the 1-year survival data for
the study by Jost et al. [15] are based on Kaplan-Meier
survival estimates, which showed a survival probability
of 10.6% in the intervention group and 7.6% in the con-
trol group (P = 0.45).
Conclusions
The results of this meta-analysis demonstrate that survi-
val is equivocal for the chest compression-first group as
compared to the defibrillation-first group. Thus, current
guidelines emphasizing early defibrillation still appear
appropriate. However, the study revealed signals toward
possible superiority of predefibrillation chest compres-
sions for patients with a response interval of >5 min;
the statistical power of this study was insufficient for
such subgroup analyses, and none reached statistical sig-
nificance. These signals suggest that the optimal treat-
ment of cardiac arrest patients may depend on the
duration of the event and the timeliness of the response.
Future research will need to be conducted to assess
whether this differential effect is seen in patients treated
for out-of-hospital cardiac arrest. This may lead to dif-
ferent treatment guidelines based on the duration of the
arrest and the interval of the response.
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